NFAT5-mediated expression of S100A4 contributes to proliferation and migration of renal carcinoma cells

Frontiers in Physiology

Volumn 5 AUG, Issue , 2014, Pages

  Küper, Christoph ^a   Beck, Franz Xaver ^a   Neuhofer, Wolfgang ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

CaKi 1; Cell migration; Cell proliferation; NFAT5; Renal cell carcinoma; S100A4

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CALVASCULIN; FOCAL ADHESION KINASE; FOCAL ADHESION KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PF 228; PROTEIN TYROSINE KINASE INHIBITOR; SMALL INTERFERING RNA; SRCL 1; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT5; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL LINE; CARCINOGENESIS; CARCINOMA CELL; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CARCINOMA; KIDNEY TUBULE CELL; OSMOTIC STRESS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84906501028     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00293     Document Type: Article

References (53)

1. Alvarez-Diaz, S., Valle, N., Ferrer-Mayorga, G., Lombardia, L., Herrera, M., Dominguez, O., et al. (2012). MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells. Hum. Mol. Genet . 21, 2157-2165. doi: 10.1093/hmg/dds031
2. Bandiera, A., Melloni, G., Freschi, M., Giovanardi, M., Carretta, A., Borri, A., et al. (2009). Prognostic factors and analysis of S100a4 protein in resected pulmonary metastases from renal cell carcinoma. World J. Surg . 33, 1414-1420. doi: 10.1007/s00268-009-0023-5
3. Chen, M., Sastry, S. K., and O'Connor, K. L. (2011). Src kinase pathway is involved in NFAT5-mediated S100A4 induction by hyperosmotic stress in colon cancer cells. Am. J. Physiol. Cell Physiol . 300, C1155-C1163. doi: 10.1152/ajpcell.00407.2010
4. Chen, M., Sinha, M., Luxon, B. A., Bresnick, A. R., and O'Connor, K. L. (2009). Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin. J. Biol. Chem . 284, 1484-1494. doi: 10.1074/jbc.M803997200
5. Chen, Q., Shinohara, N., Abe, T., Watanabe, T., Nonomura, K., and Koyanagi, T. (2004). Significance of COX-2 expression in human renal cell carcinoma cell lines. Int. J. Cancer 108, 825-832. doi: 10.1002/ijc.11646
6. Cheung, C. Y., and Ko, B. C. (2013). NFAT5 in cellular adaptation to hypertonic stress-regulations and functional significance. J. Mol. Signal . 8:5. doi: 10.1186/1750-2187-8-5
7. Chintalapudi, M. R., Markiewicz, M., Kose, N., Dammai, V., Champion, K. J., Hoda, R. S., et al. (2008). Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells. Carcinogenesis 29, 696-703. doi: 10.1093/carcin/bgn019
8. Ciocca, D. R., and Calderwood, S. K. (2005). Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10, 86-103. doi: 10.1379/CSC-99r.1
9. Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., et al. (2002). Mutations of the BRAF gene in human cancer. Nature 417, 949-954. doi: 10.1038/nature00766
10. Favale, N. O., Casali, C. I., Lepera, L. G., Pescio, L. G., and Fernandez-Tome, M. C. (2009). Hypertonic induction of COX2 expression requires TonEBP/NFAT5 in renal epithelial cells. Biochem. Biophys. Res. Commun . 381, 301-305. doi: 10.1016/j.bbrc.2008.12.189
11. Friday, B. B., Yu, C., Dy, G. K., Smith, P. D., Wang, L., Thibodeau, S. N., et al. (2008). BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins. Cancer Res . 68, 6145-6153. doi: 10.1158/0008-5472.CAN-08-1430
12. Garrett, S. C., Varney, K. M., Weber, D. J., and Bresnick, A. R. (2006). S100A4, a mediator of metastasis. J. Biol. Chem . 281, 677-680. doi: 10.1074/jbc.R500017200
13. Germann, S., Gratadou, L., Zonta, E., Dardenne, E., Gaudineau, B., Fougere, M., et al. (2012). Dual role of the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 transcription factor. Oncogene 31, 4536-4549. doi: 10.1038/onc.2011.618
14. Gomella, L. G., Sargent, E. R., Wade, T. P., Anglard, P., Linehan, W. M., and Kasid, A. (1989). Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma. Cancer Res . 49, 6972-6975.
15. Gunaratnam, L., Morley, M., Franovic, A., De Paulsen, N., Mekhail, K., Parolin, D. A., et al. (2003). Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells. J. Biol. Chem . 278, 44966-44974. doi: 10.1074/jbc.M305502200
16. Halterman, J. A., Kwon, H. M., and Wamhoff, B. R. (2012). Tonicity-independent regulation of the osmosensitive transcription factor TonEBP (NFAT5). Am. J. Physiol. Cell Physiol . 302, C1-C8. doi: 10.1152/ajpcell.00327.2011
17. Han, K. H., Woo, S. K., Kim, W. Y., Park, S. H., Cha, J. H., Kim, J., et al. (2004). Maturation of TonEBP expression in developing rat kidney. Am. J. Physiol. Renal Physiol . 287, F878-F885. doi: 10.1152/ajprenal.00047.2004
18. Jauliac, S., Lopez-Rodriguez, C., Shaw, L. M., Brown, L. F., Rao, A., and Toker, A. (2002). The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat. Cell Biol . 4, 540-544. doi: 10.1038/ncb816
19. Kojima, R., Taniguchi, H., Tsuzuki, A., Nakamura, K., Sakakura, Y., and Ito, M. (2010). Hypertonicity-induced expression of monocyte chemoattractant protein-1 through a novel cis-acting element and MAPK signaling pathways. J. Immunol . 184, 5253-5262. doi: 10.4049/jimmunol.0901298
20. Kultz, D., Garcia-Perez, A., Ferraris, J. D., and Burg, M. B. (1997). Distinct regulation of osmoprotective genes in yeast and mammals. Aldose reductase osmotic response element is induced independent of p38 and stress-activated protein kinase/Jun N-terminal kinase in rabbit kidney cells. J. Biol. Chem . 272, 13165-13170. doi: 10.1074/jbc.272.20.13165
21. Küper, C., Steinert, D., Fraek, M. L., Beck, F. X., and Neuhofer, W. (2009). EGF receptor signaling is involved in expression of osmoprotective TonEBP target gene aldose reductase under hypertonic conditions. Am. J. Physiol. Renal Physiol . 296, F1100-F1108. doi: 10.1152/ajprenal.90402.2008
22. Lee, J. H., Kim, M., Im, Y. S., Choi, W., Byeon, S. H., and Lee, H. K. (2008). NFAT5 induction and its role in hyperosmolar stressed human limbal epithelial cells. Invest. Ophthalmol. Vis. Sci . 49, 1827-1835. doi: 10.1167/iovs.07-1142
23. Levy, C., Khaled, M., Iliopoulos, D., Janas, M. M., Schubert, S., Pinner, S., et al. (2010). Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol. Cell 40, 841-849. doi: 10.1016/j.molcel.2010.11.020
24. Liang, C. C., Park, A. Y., and Guan, J. L. (2007). In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro . Nat. Protoc . 2, 329-333. doi: 10.1038/nprot.2007.30
25. Linehan, W. M., Walther, M. M., and Zbar, B. (2003). The genetic basis of cancer of the kidney. J. Urol . 170, 2163-2172. doi: 10.1097/01.ju.0000096060.92397.ed
26. Lopez-Lago, M. A., Thodima, V. J., Guttapalli, A., Chan, T., Heguy, A., Molina, A. M., et al. (2010). Genomic deregulation during metastasis of renal cell carcinoma implements a myofibroblast-like program of gene expression. Cancer Res . 70, 9682-9692. doi: 10.1158/0008-5472.CAN-10-2279
27. McCarthy-Keith, D. M., Malik, M., Britten, J., Segars, J., and Catherino, W. H. (2011). Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells. Fertil. Steril . 95, 2383-2387. doi: 10.1016/j.fertnstert.2011.03.084
28. Mijatovic, T., Mathieu, V., Gaussin, J. F., De Neve, N., Ribaucour, F., Van Quaquebeke, E., et al. (2006). Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers. Neoplasia 8, 402-412. doi: 10.1593/neo.05850
29. Mitra, S. K., and Schlaepfer, D. D. (2006). Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol . 18, 516-523. doi: 10.1016/j.ceb.2006.08.011
30. Miyakawa, H., Woo, S. K., Chen, C. P., Dahl, S. C., Handler, J. S., and Kwon, H. M. (1998). Cis- and trans-acting factors regulating transcription of the BGT1 gene in response to hypertonicity. Am. J. Physiol . 274, F753-F761.
31. Miyakawa, H., Woo, S. K., Dahl, S. C., Handler, J. S., and Kwon, H. M. (1999). Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proc. Natl. Acad. Sci. U.S.A . 96, 2538-2542. doi: 10.1073/pnas.96.5.2538
32. Morancho, B., Minguillon, J., Molkentin, J. D., Lopez-Rodriguez, C., and Aramburu, J. (2008). Analysis of the transcriptional activity of endogenous NFAT5 in primary cells using transgenic NFAT-luciferase reporter mice. BMC Mol. Biol . 9:13. doi: 10.1186/1471-2199-9-13
33. Motzer, R. J. (2011). New perspectives on the treatment of metastatic renal cell carcinoma: an introduction and historical overview. Oncologist 16(Suppl. 2), 1-3. doi: 10.1634/theoncologist.2011-S2-01
34. Muller, M. R., and Rao, A. (2010). NFAT, immunity and cancer: a transcription factor comes of age. Nat. Rev. Immunol . 10, 645-656. doi: 10.1038/nri2818
35. Neuhofer, W., Kuper, C., Lichtnekert, J., Holzapfel, K., Rupanagudi, K. V., Fraek, M. L., et al. (2014). Focal adhesion kinase regulates the activity of the osmosensitive transcription factor TonEBP/NFAT5 under hypertonic conditions. Front. Physiol . 5:123. doi: 10.3389/fphys.2014.00123
36. Neuhofer, W., Steinert, D., Fraek, M. L., and Beck, F. X. (2007). Prostaglandin E2 stimulates expression of osmoprotective genes in MDCK cells and promotes survival under hypertonic conditions. J. Physiol . 583, 287-297. doi: 10.1113/jphysiol.2007.135178
37. O'Connor, R. S., Mills, S. T., Jones, K. A., Ho, S. N., and Pavlath, G. K. (2007). A combinatorial role for NFAT5 in both myoblast migration and differentiation during skeletal muscle myogenesis. J. Cell Sci . 120, 149-159. doi: 10.1242/jcs.03307
38. Patel, P. H., Chadalavada, R. S., Chaganti, R. S., and Motzer, R. J. (2006). Targeting von Hippel-Lindau pathway in renal cell carcinoma. Clin. Cancer Res . 12, 7215-7220. doi: 10.1158/1078-0432.CCR-06-2254
39. Pelletier, S., Tanguay, S., Lee, S., Gunaratnam, L., Arbour, N., and Lapointe, R. (2009). TGF-alpha as a candidate tumor antigen for renal cell carcinomas. Cancer Immunol. Immunother . 58, 1207-1218. doi: 10.1007/s00262-008-0630-2
40. Qayyum, T., McArdle, P. A., Lamb, G. W., Jordan, F., Orange, C., Seywright, M., et al. (2012). Expression and prognostic significance of Src family members in renal clear cell carcinoma. Br. J. Cancer 107, 856-863. doi: 10.1038/bjc.2012.314
41. Ramp, U., Mahotka, C., Heikaus, S., Shibata, T., Grimm, M. O., Willers, R., et al. (2007). Expression of heat shock protein 70 in renal cell carcinoma and its relation to tumor progression and prognosis. Histol. Histopathol . 22, 1099-1107.
42. Rivard, C. J., Brown, L. M., Almeida, N. E., Maunsbach, A. B., Pihakaski-Maunsbach, K., Andres-Hernando, A., et al. (2007). Expression of the calcium-binding protein S100A4 is markedly up-regulated by osmotic stress and is involved in the renal osmoadaptive response. J. Biol. Chem . 282, 6644-6652. doi: 10.1074/jbc.M609432200
43. Roberts, P. J., and Der, C. J. (2007). Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26, 3291-3310. doi: 10.1038/sj.onc.1210422
44. Roth, I., Leroy, V., Kwon, H. M., Martin, P. Y., Feraille, E., and Hasler, U. (2010). Osmoprotective transcription factor NFAT5/TonEBP modulates nuclear factor-kappaB activity. Mol. Biol. Cell 21, 3459-3474. doi: 10.1091/mbc.E10-02-0133
45. Siegel, R., Naishadham, D., and Jemal, A. (2012). Cancer statistics, 2012. CA Cancer J. Clin . 62, 10-29. doi: 10.3322/caac.20138
46. Slattery, M. L., Lundgreen, A., Bondurant, K. L., and Wolff, R. K. (2011). Tumor necrosis factor-related genes and colon and rectal cancer. Int. J. Mol. Epidemiol. Genet . 2, 328-338.
47. Tsai, T. T., Guttapalli, A., Agrawal, A., Albert, T. J., Shapiro, I. M., and Risbud, M. V. (2007). MEK/ERK signaling controls osmoregulation of nucleus pulposus cells of the intervertebral disc by transactivation of TonEBP/OREBP. J. Bone Miner. Res . 22, 965-974. doi: 10.1359/jbmr.070322
48. Wang, L. J., Matoso, A., Sciandra, K. T., Yakirevich, E., Sabo, E., Zhang, Y., et al. (2012). Expression of S100A4 in renal epithelial neoplasms. Appl. Immunohistochem. Mol. Morphol . 20, 71-76. doi: 10.1097/PAI.0b013e31821fc8b7
49. Woo, S. K., Lee, S. D., Na, K. Y., Park, W. K., and Kwon, H. M. (2002). TonEBP/NFAT5 stimulates transcription of HSP70 in response to hypertonicity. Mol. Cell. Biol . 22, 5753-5760. doi: 10.1128/MCB.22.16.5753-5760.2002
50. Yang, H., Zhao, K., Yu, Q., Wang, X., Song, Y., and Li, R. (2012). Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma. J. Int. Med. Res . 40, 475-485. doi: 10.1177/147323001204000209
51. Yang, X. C., Wang, X., Luo, L., Dong, D. H., Yu, Q. C., Wang, X. S., et al. (2013). RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway. Eur. Rev. Med. Pharmacol. Sci . 17, 1669-1680.
52. Zhang, Z., Ferraris, J. D., Brooks, H. L., Brisc, I., and Burg, M. B. (2003). Expression of osmotic stress-related genes in tissues of normal and hyposmotic rats. Am. J. Physiol. Renal Physiol . 285, F688-F693. doi: 10.1152/ajprenal.00028.2003
53. Zhong, L., Peng, X., Hidalgo, G. E., Doherty, D. E., Stromberg, A. J., and Hirschowitz, E. A. (2004). Identification of circulating antibodies to tumor-associated proteins for combined use as markers of non-small cell lung cancer. Proteomics 4, 1216-1225. doi: 10.1002/pmic.200200679